From: Better care for people with diabetes and endocrine diseases
| Class of drug | Year first approved in US |
|---|---|
| 1. Insulin | |
| •Animal insulins | 1923 |
| •Human insulins | 1982 |
| •Insulin analogs | 1996 |
| 2. Sulfonylureas | 1955 |
| 3. Biguanide-Metformin | 1995 (1957 in Europe) |
| 4. Alpha glucosidase inhibitors | 1995 (1990 in Germany) |
| 5. Amylin analog | 1995 |
| 6. Thiazolidinediones | 1997 |
| 7. Glucagon-like peptide receptor agonists | 2005 |
| 8. Dipeptidyl-peptidase inhibitors | 2006 |
| 9. Bile acid sequestrant-Colesevelam | 2008 |
| 10. Dopamine agonist-Bromocryptine | 2009 |
| 11. Sodium-glucose co-transporter 2 inhibitors | 2013 |